These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25744864)

  • 1. Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.
    Gambini D; Visintin R; Locatelli E; Bareggi C; Galassi B; Runza L; Blundo C; Sosnovskikh I; Tomirotti M
    Tumori; 2015 Apr; 101(2):e60-3. PubMed ID: 25744864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma.
    Gambini D; Visintin R; Locatelli E; Galassi B; Bareggi C; Runza L; Onida F; Tomirotti M
    Tumori; 2009; 95(6):828-31. PubMed ID: 20210253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to paclitaxel in a radiotherapy-induced breast angiosarcoma.
    Perez-Ruiz E; Ribelles N; Sanchez-Muñoz A; Roman A; Marquez A
    Acta Oncol; 2009; 48(7):1078-9. PubMed ID: 19235566
    [No Abstract]   [Full Text] [Related]  

  • 4. Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.
    Schlemmer M; Reichardt P; Verweij J; Hartmann JT; Judson I; Thyss A; Hogendoorn PC; Marreaud S; Van Glabbeke M; Blay JY
    Eur J Cancer; 2008 Nov; 44(16):2433-6. PubMed ID: 18771914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
    Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
    J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiosarcoma of the breast: a difficult surgical challenge.
    Hui A; Henderson M; Speakman D; Skandarajah A
    Breast; 2012 Aug; 21(4):584-9. PubMed ID: 22305554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage weekly paclitaxel in recurrent ovarian cancer.
    Abu-Rustum NR; Aghajanian C; Barakat RR; Fennelly D; Shapiro F; Spriggs D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-62-S15-67. PubMed ID: 9346225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
    Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen DP; Schwartz GK; Casper ES
    Cancer; 1999 Nov; 86(10):2034-7. PubMed ID: 10570428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosarcoma associated with a Kasabach-Merritt syndrome: report of two cases treated with paclitaxel.
    Grellety T; Italiano A
    Future Oncol; 2013 Sep; 9(9):1397-9. PubMed ID: 23980686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy.
    Mano MS; Fraser G; Kerr J; Gray M; Evans V; Kazmi A; Canney P
    Breast; 2006 Feb; 15(1):117-8. PubMed ID: 16473744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel as a first-line chemotherapy for Japanese women with advanced or recurrent breast cancer: a multi-institutional practice-based study by the Kyushu Breast Cancer Study Group (KBC-SG).
    Ishikawa M; Takamatsu Y; Mitsuyama S; Iwakuma N; Anan K; Umeda S; Tamura K
    Breast Cancer; 2010 Apr; 17(2):131-5. PubMed ID: 19472037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly paclitaxel may improve locoregional recurrence by decreasing interstitial fluid pressure in operable node-positive breast cancer patients.
    Altundag K; Altundag O; Boruban C; Altundag MB; Turen S
    Med Hypotheses; 2006; 66(1):211-2. PubMed ID: 15950399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two cases of effective weekly paclitaxel administration and concurrent radiation for metastatic breast cancer].
    Kokufu I; Tanei T; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K; Tamaoka K; Hosono M
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):111-4. PubMed ID: 12557714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly paclitaxel--an effective treatment for advanced breast cancer.
    Kellokumpu-Lehtinen P; Tuunanen T; Asola R; Elomaa L; Heikkinen M; Kokko R; Järvenpää R; Lehtinen I; Maiche A; Kaleva-Kerola J; Huusko M; Möykkynen K; Ala-Luhtala T
    Anticancer Res; 2013 Jun; 33(6):2623-7. PubMed ID: 23749918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiosarcoma of the breast with delay in diagnosis.
    Deutsch M; Werner R
    Clin Adv Hematol Oncol; 2004 May; 2(5):320; discussion 321. PubMed ID: 16163199
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital angiosarcoma with transient response to paclitaxel.
    Good AB; Nascimento A; Welker KM; Arndt CA
    J Pediatr Hematol Oncol; 2008 Jun; 30(6):451-3. PubMed ID: 18525462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Will weekly work"? Seems to be so...
    Seidman AD
    J Clin Oncol; 2005 Sep; 23(25):5873-4. PubMed ID: 16087954
    [No Abstract]   [Full Text] [Related]  

  • 18. Weekly high-dose paclitaxel in metastatic and locally advanced breast cancer: a preliminary report.
    Akerley W; Sikov WM; Cummings F; Safran H; Strenger R; Marchant D
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-87-S17-90. PubMed ID: 9374102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in patients with sickle cell disease can be treated safely with weekly paclitaxel.
    Al Zaman AS
    Saudi Med J; 2013 Feb; 34(2):199-201. PubMed ID: 23396470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cardiac angiosarcoma with good response to Paclitaxel.
    Ram Prabu MP; Thulkar S; Ray R; Bakhshi S
    J Thorac Oncol; 2011 Oct; 6(10):1778-9. PubMed ID: 21918397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.